Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimzia for Crohn's Disease Response Optimization
NCT01024647Phase 4Unknown
- Sponsor
- Atlanta Gastroenterology Associates
- Start
- Dec 2009
- Primary completion
- May 2013
- Countries
- 1
01
Overview
A Phase 4 trial of certolizumab pegol in Crohn's disease, sponsored by Atlanta Gastroenterology Associates. Status: unknown.
02
Drugs
certolizumab pegol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01024647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024647.